| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |